These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 14510794
1. Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Arend O, Harris A, Wolter P, Remky A. Acta Ophthalmol Scand; 2003 Oct; 81(5):474-9. PubMed ID: 14510794 [Abstract] [Full Text] [Related]
2. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma. Siesky B, Harris A, Sines D, Rechtman E, Malinovsky VE, McCranor L, Yung CW, Zalish M. J Ocul Pharmacol Ther; 2006 Oct; 22(5):353-61. PubMed ID: 17076630 [Abstract] [Full Text] [Related]
3. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma. Polo V, Larrosa JM, Gomez ML, Pablo L, Honrubia FM. Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277 [Abstract] [Full Text] [Related]
4. Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. Harris A, Migliardi R, Rechtman E, Cole CN, Yee AB, Garzozi HJ. Eur J Ophthalmol; 2003 Feb; 13(1):24-31. PubMed ID: 12635671 [Abstract] [Full Text] [Related]
5. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece. Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N. J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817 [Abstract] [Full Text] [Related]
6. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group. García Sanchez J. Eur J Ophthalmol; 2000 Aug; 10(3):198-204. PubMed ID: 11071026 [Abstract] [Full Text] [Related]
7. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients. Janulevicienë I, Harris A, Kagemann L, Siesky B, McCranor L. Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472 [Abstract] [Full Text] [Related]
8. Latanoprost versus combined timolol and dorzolamide. Bron AM, Emmerich KH. Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S148-54. PubMed ID: 12204712 [Abstract] [Full Text] [Related]
9. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma. Eren MH, Gungel H, Altan C, Pasaoglu IB, Sabanci S. J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418 [Abstract] [Full Text] [Related]
10. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC. Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169 [Abstract] [Full Text] [Related]
11. Additive effect of latanoprost to the combination of timolol and dorzolamide. Susanna R, Nicolela MT, Oga E. J Glaucoma; 2000 Apr; 9(2):183-6. PubMed ID: 10782630 [Abstract] [Full Text] [Related]
12. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Tamer C, Oksüz H. Ophthalmic Res; 2007 Apr; 39(1):24-31. PubMed ID: 17164574 [Abstract] [Full Text] [Related]
13. Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association. Italian Multicentric Open Randomized Study under the aegis of A.I.S.G.: Final Results and Official Report. Acta Ophthalmol Scand Suppl; 2000 Apr; (232):49-50. PubMed ID: 11235535 [No Abstract] [Full Text] [Related]
14. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E. Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034 [Abstract] [Full Text] [Related]
15. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568 [Abstract] [Full Text] [Related]
16. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America. Susanna R, Sheu WP, Latin American Glaucoma Society. Clin Ther; 2004 May; 26(5):755-68. PubMed ID: 15220019 [Abstract] [Full Text] [Related]
17. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients. Martínez A, Sánchez M. Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432 [Abstract] [Full Text] [Related]
18. Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy. Siesky B, Harris A, Kagemann L, Stefansson E, McCranor L, Miller B, Bwatwa J, Regev G, Ehrlich R. Acta Ophthalmol; 2010 Feb; 88(1):142-9. PubMed ID: 19706018 [Abstract] [Full Text] [Related]
19. Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study. Emmerich KH. Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):19-23. PubMed ID: 10664047 [Abstract] [Full Text] [Related]
20. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study. Chiseliţă D, Antohi I, Medvichi R, Danielescu C. Oftalmologia; 2005 Jan; 49(3):39-45. PubMed ID: 16408674 [Abstract] [Full Text] [Related] Page: [Next] [New Search]